---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-08T20:24:23.299957'
end_time: '2026-02-08T20:30:09.398319'
duration_seconds: 346.1
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: COPS8
  gene_symbol: COPS8
  uniprot_accession: Q99627
  protein_description: 'RecName: Full=COP9 signalosome complex subunit 8; Short=SGN8;
    Short=Signalosome subunit 8; AltName: Full=COP9 homolog; Short=hCOP9; AltName:
    Full=JAB1-containing signalosome subunit 8;'
  gene_info: Name=COPS8; Synonyms=CSN8;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the CSN8 family. .
  protein_domains: COP9_CSN8. (IPR033205); CSN8_PSD8_EIF3K. (IPR033464); PCI_dom.
    (IPR000717); CSN8_PSD8_EIF3K (PF10075)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 11
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q99627
- **Protein Description:** RecName: Full=COP9 signalosome complex subunit 8; Short=SGN8; Short=Signalosome subunit 8; AltName: Full=COP9 homolog; Short=hCOP9; AltName: Full=JAB1-containing signalosome subunit 8;
- **Gene Information:** Name=COPS8; Synonyms=CSN8;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the CSN8 family. .
- **Key Domains:** COP9_CSN8. (IPR033205); CSN8_PSD8_EIF3K. (IPR033464); PCI_dom. (IPR000717); CSN8_PSD8_EIF3K (PF10075)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "COPS8" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'COPS8' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **COPS8** (gene ID: COPS8, UniProt: Q99627) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q99627
- **Protein Description:** RecName: Full=COP9 signalosome complex subunit 8; Short=SGN8; Short=Signalosome subunit 8; AltName: Full=COP9 homolog; Short=hCOP9; AltName: Full=JAB1-containing signalosome subunit 8;
- **Gene Information:** Name=COPS8; Synonyms=CSN8;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the CSN8 family. .
- **Key Domains:** COP9_CSN8. (IPR033205); CSN8_PSD8_EIF3K. (IPR033464); PCI_dom. (IPR000717); CSN8_PSD8_EIF3K (PF10075)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "COPS8" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'COPS8' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **COPS8** (gene ID: COPS8, UniProt: Q99627) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan overview
Objectives were defined to: verify identity for human COPS8 (CSN8; UniProt Q99627), gather recent literature (prioritizing 2023–2024), extract mechanistic and localization evidence, compile recent disease/translation findings, and synthesize a concise artifact and full report with citations.

Verification of target identity and domains
- Gene/protein identity: COPS8 (synonym CSN8) encodes the eighth canonical subunit of the human COP9 signalosome (CSN), an evolutionarily conserved eight-subunit complex. This aligns with UniProt Q99627 and the target description. Contemporary reviews reaffirm the eight-subunit architecture and subfamily composition (PCI-domain subunits and MPN-domain subunits) for the human CSN, with CSN8 falling within the PCI-domain cohort (review synthesis). (dubiel2024comparisonoftwo pages 4-5)
- Organism: Homo sapiens (human) studies and reviews cited herein examine the human CSN and its subunits, including COPS8/CSN8. (liu2024cop9signalosomecomplex pages 12-16, dubiel2024comparisonoftwo pages 4-5)
- Domain/family: CSN8 is one of the PCI-domain subunits of the CSN; the complex contains six PCI-domain subunits (including CSN8) and two MPN subunits (CSN5/CSN6), consistent with the PCI_dom annotation provided. (dubiel2024comparisonoftwo pages 4-5)
- No symbol ambiguity detected for human COPS8/CSN8 in the cited sources; research specifically refers to the human COP9 signalosome subunit 8.

Key concepts and definitions (current understanding)
- COP9 signalosome (CSN) function: The CSN is a master regulator of cullin–RING E3 ligases (CRLs). Its core enzymatic activity is deneddylation—the removal of the ubiquitin-like modifier NEDD8 from cullin scaffolds—which turns over CRL activation cycles and thereby tunes substrate ubiquitination rates. CSN5 (JAB1) harbors the JAMM/MPN metalloprotease activity responsible for deneddylation within the assembled complex. (Review and cancer-focused analysis, with URLs and dates: Frontiers in Cell and Developmental Biology, Nov 2024, https://doi.org/10.3389/fcell.2024.1496862; Aging, Mar 2024, https://doi.org/10.18632/aging.205646) (dubiel2024comparisonoftwo pages 4-5, liu2024cop9signalosomecomplex pages 12-16)
- COPS8 (CSN8) role within CSN: CSN8 is a structural PCI-domain subunit required for holocomplex integrity. Perturbation (hypomorphism) of CSN8 destabilizes the CSN holocomplex, with consequences for CRL regulation and additional CSN5-dependent functions (see Recent developments and Vascular remodeling sections). (bioRxiv preprint, Apr 2023, https://doi.org/10.1101/2023.04.11.536468) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)

Recent developments and latest research (2023–2024 priority)
- Systems/comparative review: A 2024 review compared the CSN with the 26S proteasome lid, summarizing up-to-date mechanistic understanding of deneddylation, CSN–proteasome/SCF interactions, and variant CSN assemblies with roles in DNA damage response. It consolidates the placement of CSN5 as the deneddylase and highlights CSN’s regulatory reach across CRLs and stress pathways. (Frontiers in Cell and Developmental Biology, Nov 2024, https://doi.org/10.3389/fcell.2024.1496862) (dubiel2024comparisonoftwo pages 4-5)
- Cancer transcriptomic/prognostic update: In hepatocellular carcinoma (HCC), the CSN subunits are broadly upregulated with associations to poorer overall survival; functional assays reported that overexpression of certain subunits, including COPS8, enhanced proliferation, EMT, and vascular invasion. Multivariate analyses identified COPS5, COPS7B, and COPS9 as independent prognostic biomarkers. This work integrates TCGA, HPA, and immunohistochemistry, and explores immune infiltration correlations. (Aging, Mar 2024, 16:5264–5287, https://doi.org/10.18632/aging.205646) (liu2024cop9signalosomecomplex pages 12-16)
- Vascular remodeling mechanism implicating CSN8: A 2023 mechanistic preprint demonstrated that CSN8 hypomorphism leads to CSN holocomplex destabilization and accumulation of cytoplasmic CSN5 “mini-complexes.” In vascular smooth muscle cells (VSMCs), this state drives hyperproliferation and neointimal hyperplasia via a deneddylation-independent mechanism centered on CSN5-mediated nuclear export of p27; conversely, smooth muscle-specific deletion of CSN5 suppresses proliferation and neointimal growth. Pharmacologic CSN5 inhibition (CSN5i-3) blunted neointima formation in wild-type settings but did not rescue the CSN8-hypomorphic phenotype and showed moderate cardiotoxicity, prompting suggestions for local delivery strategies. (bioRxiv, posted Apr 12, 2023, https://doi.org/10.1101/2023.04.11.536468) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)

Primary function, mechanism, and pathway context
- Biochemical role: COPS8 is a PCI-domain scaffold subunit of the CSN holocomplex; by maintaining complex integrity, it enables CSN5-dependent deneddylation of cullins and the associated turnover of active CRLs. This positions COPS8 upstream of broad ubiquitin-mediated proteostasis and signaling flux. (Frontiers in Cell and Developmental Biology, Nov 2024, https://doi.org/10.3389/fcell.2024.1496862; Aging, Mar 2024, https://doi.org/10.18632/aging.205646) (dubiel2024comparisonoftwo pages 4-5, liu2024cop9signalosomecomplex pages 12-16)
- Pathways and signaling: CSN-regulated CRL activity interfaces with p53, c-Jun/AP‑1, and NF‑κB/IκBα signaling axes, influencing cell cycle, stress, and inflammatory responses. Bioinformatic protein–protein interaction analysis in HCC highlighted strong CSN links to p53 and multiple cullins. (Aging, Mar 2024, https://doi.org/10.18632/aging.205646) (liu2024cop9signalosomecomplex pages 12-16)
- DNA damage response: Variant CSN assemblies and CSN functions contribute to DNA damage signaling and repair pathways, as summarized by the 2024 review, underscoring CSN’s integration with stress responses beyond proteostasis. (Frontiers in Cell and Developmental Biology, Nov 2024, https://doi.org/10.3389/fcell.2024.1496862) (dubiel2024comparisonoftwo pages 4-5)

Subcellular localization and site of action
- The CSN operates in both cytoplasm and nucleus to control CRL activity and related signaling. In CSN8-hypomorphic cells and injured vessels, cytoplasmic CSN5-containing mini-complexes accumulate and promote nuclear export of p27, providing direct evidence of nucleo‑cytoplasmic functional interplay when CSN8 is compromised. (bioRxiv, Apr 2023, https://doi.org/10.1101/2023.04.11.536468) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)

Current applications and real-world implementations
- Biomarkers in oncology: CSN subunits, including COPS8, are candidate prognostic biomarkers in HCC; integrative clinical modeling (Kaplan–Meier, Cox regression, ROC, nomograms) supports the prognostic utility of a CSN signature, including immune infiltration correlations with COPS expression. (Aging, Mar 2024, https://doi.org/10.18632/aging.205646) (liu2024cop9signalosomecomplex pages 12-16)
- Therapeutic concepts in vascular disease: Preclinical inhibition of CSN5 (CSN5i-3) reduced neointimal hyperplasia, supporting CSN5/CSN targeting to modulate VSMC proliferation and restenosis risk; toxicity observations and lack of rescue in CSN8 hypomorphism suggest context-dependent strategies and potential for local delivery (e.g., drug-eluting stents). (bioRxiv, Apr 2023, https://doi.org/10.1101/2023.04.11.536468) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)

Expert opinions and analysis from authoritative sources
- Comparative 2024 review perspective: The CSN is framed as a central UPS regulator akin to the proteasome lid, with a “neddylation–deneddylation cycle” driving substrate processing by CRLs. The review emphasizes therapeutic targeting possibilities while cautioning on the complexity of CSN variants and pathway crosstalk in DNA damage and cancer. (Frontiers in Cell and Developmental Biology, Nov 2024, https://doi.org/10.3389/fcell.2024.1496862) (dubiel2024comparisonoftwo pages 4-5)
- Cancer bioinformatics/functional synthesis (2024): The HCC study’s multilevel integration posits a practical route to clinical adoption of CSN-based prognostic signatures and motivates mechanistic follow-up on specific subunits, including COPS8, that enhance EMT and invasiveness when overexpressed. (Aging, Mar 2024, https://doi.org/10.18632/aging.205646) (liu2024cop9signalosomecomplex pages 12-16)

Relevant statistics and recent data points
- HCC cohort analytics: The HCC analysis incorporated multi-omics databases and immunohistochemistry; expression of multiple CSN subunits was significantly upregulated in HCC and associated with shorter overall survival; COPS5, COPS7B, COPS9 were independent prognostic biomarkers in multivariate Cox models. The study included paired tumor/adjacent tissues and immune infiltration analyses (TIMER/TISIDB/ssGSEA/ESTIMATE). (Aging, Mar 2024, https://doi.org/10.18632/aging.205646) (liu2024cop9signalosomecomplex pages 12-16)
- Vascular remodeling models: In mouse left common carotid artery ligation, CSN subunit expression rose in injured vessels; smooth-muscle CSN5 knockout inhibited proliferation and neointima, while CSN8 hypomorphism exacerbated both. CSN5 pharmacologic inhibition (CSN5i-3) reduced neointima in wild-type but not in CSN8-hypomorphic conditions; toxicity signals were noted with systemic dosing. (bioRxiv, Apr 2023, https://doi.org/10.1101/2023.04.11.536468) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)
- Melanoma: Elevated COPS8 expression correlated with poor survival; knockdown reduced proliferation, migration, and invasion and reversed EMT marker trends, supporting an oncogenic role. (Bioscience, Biotechnology, and Biochemistry, Feb 2021, https://doi.org/10.1093/bbb/zbaa017) (sun2021cops8incutaneous pages 6-8)

Embedded summary artifact
| Aspect | Summary | Key Evidence/Notes | Source (with URL and date) |
|---|---|---|---|
| Identity | COPS8 encodes CSN8, the eighth subunit of the eight-member COP9 signalosome (PCI-domain family), a conserved multisubunit complex. | CSN composition and PCI-family assignment are described in recent CSN reviews. (dubiel2024comparisonoftwo pages 4-5) | https://doi.org/10.3389/fcell.2024.1496862 (Nov 2024) (dubiel2024comparisonoftwo pages 4-5) |
| Core function | The COP9 signalosome regulates cullin-RING E3 ligases by removing NEDD8 (deneddylation); CSN5 contains the catalytic JAMM/MPN metalloprotease activity. | Deneddylation of cullins by CSN controls CRL activity and downstream ubiquitination. (liu2024cop9signalosomecomplex pages 12-16, dubiel2024comparisonoftwo pages 4-5) | https://doi.org/10.18632/aging.205646 (Mar 2024); https://doi.org/10.3389/fcell.2024.1496862 (Nov 2024) (liu2024cop9signalosomecomplex pages 12-16, dubiel2024comparisonoftwo pages 4-5) |
| COPS8-specific roles | CSN8 hypomorphism destabilizes the CSN holocomplex, promotes formation of cytoplasmic CSN5 "mini-complexes," and is linked to altered cell-cycle control and increased proliferation in vascular smooth muscle cells. | Functional preclinical data show CSN8-hypo increases VSMC proliferation and neointimal hyperplasia via a CSN5-mediated, nuclear-export mechanism. (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20) | https://doi.org/10.1101/2023.04.11.536468 (Apr 2023) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20) |
| Localization | The CSN functions in both nucleus and cytoplasm; CSN5-containing mini-complexes were observed in the cytoplasm, and CSN activity affects nucleo-cytoplasmic trafficking (e.g., p27 nuclear export). | Subcellular shifts of CSN subunits (CSN5 nuclear export / cytoplasmic mini-complexes) linked to altered cell-cycle regulator localization. (giri2023cop9signalosomepromotes pages 1-5) | https://doi.org/10.1101/2023.04.11.536468 (Apr 2023) (giri2023cop9signalosomepromotes pages 1-5) |
| Disease associations — cancer | Multiple COPS subunits are upregulated in cancers; COPS8 overexpression associates with poorer prognosis in HCC and functions as an oncogene in cutaneous melanoma promoting EMT. | Transcriptomic/prognostic analyses in HCC and a functional study in melanoma report COPS8 upregulation, proliferation/EMT effects, and survival associations. (liu2024cop9signalosomecomplex pages 12-16, sun2021cops8incutaneous pages 6-8) | https://doi.org/10.18632/aging.205646 (Mar 2024); https://doi.org/10.1093/bbb/zbaa017 (Feb 2021) (liu2024cop9signalosomecomplex pages 12-16, sun2021cops8incutaneous pages 6-8) |
| Inflammation / neurological | The CSN modulates inflammatory signaling and has been implicated in neuroinflammation and ischemic neuronal stress models via effects on CRL-regulated pathways (e.g., NF-κB, Akt). | Functional studies and reviews indicate CSN-dependent deneddylation alters microglial/endothelial inflammatory responses and neuronal survival. (liu2024cop9signalosomecomplex pages 12-16, dubiel2024comparisonoftwo pages 4-5) | https://doi.org/10.18632/aging.205646 (Mar 2024); https://doi.org/10.3389/fcell.2024.1496862 (Nov 2024) (liu2024cop9signalosomecomplex pages 12-16, dubiel2024comparisonoftwo pages 4-5) |
| Vascular remodeling | CSN influences neointimal hyperplasia: CSN5 knockout in smooth muscle reduces VSMC proliferation, whereas CSN8-hypomorphism exacerbates neointima formation; increased CSN5 observed in human PAH neointima. | Preclinical ligation and VSMC studies report CSN5/CSN8-dependent effects on p27 localization, proliferation, and neointimal growth. (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20) | https://doi.org/10.1101/2023.04.11.536468 (Apr 2023) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20) |
| Applications | COP9 subunits (including COPS8) have biomarker potential in HCC; pharmacologic CSN5 inhibition (CSN5i-3) suppresses VSMC proliferation and neointima in models but has toxicity considerations. | Biomarker analyses and preclinical inhibitor studies show translational potential and caution on toxicity/delivery. (liu2024cop9signalosomecomplex pages 12-16, giri2023cop9signalosomepromotes pages 1-5) | https://doi.org/10.18632/aging.205646 (Mar 2024); https://doi.org/10.1101/2023.04.11.536468 (Apr 2023) (liu2024cop9signalosomecomplex pages 12-16, giri2023cop9signalosomepromotes pages 1-5) |
| 2023–2024 highlights | Key recent findings: 2023 preprint links CSN8 hypomorphism to vascular disease mechanisms; 2024 study identifies COP9 subunits as prognostic in HCC; 2024 review synthesizes CSN roles versus the proteasome lid. | These items capture recent mechanistic, translational, and review-level updates on CSN/COPS8 biology. (giri2023cop9signalosomepromotes pages 1-5, liu2024cop9signalosomecomplex pages 12-16, dubiel2024comparisonoftwo pages 4-5) | https://doi.org/10.1101/2023.04.11.536468 (Apr 2023); https://doi.org/10.18632/aging.205646 (Mar 2024); https://doi.org/10.3389/fcell.2024.1496862 (Nov 2024) (giri2023cop9signalosomepromotes pages 1-5, liu2024cop9signalosomecomplex pages 12-16, dubiel2024comparisonoftwo pages 4-5) |


*Table: A concise, cited table summarizing COPS8/CSN8 identity, core function, localization, disease links, recent 2023–2024 findings, and translational notes, with sources (context IDs and DOIs) for rapid reference.*

Synthesis: precise role of COPS8
- Structural and regulatory role: COPS8 (CSN8) is a PCI-domain subunit essential for CSN holocomplex integrity, enabling the CSN’s deneddylase function to control CRL activity. Its disruption (hypomorphism) reveals an additional layer of CSN biology—CSN5 mini-complex formation and altered nucleo‑cytoplasmic trafficking of p27—linking COPS8 status to cell-cycle progression in vascular smooth muscle. (Frontiers in Cell and Developmental Biology, Nov 2024, https://doi.org/10.3389/fcell.2024.1496862; bioRxiv, Apr 2023, https://doi.org/10.1101/2023.04.11.536468) (dubiel2024comparisonoftwo pages 4-5, giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)
- Pathways and disease: Through the CSN, COPS8 influences CRL-dependent turnover of key regulators across p53, AP‑1, and NF‑κB axes, contributing to cancer biology (HCC prognostic value; EMT/invasion) and vascular remodeling (neointimal hyperplasia; CSN5 nuclear export of p27). The 2024 HCC study underscores translational potential for CSN subunit signatures, while the 2023 vascular work highlights opportunities and caveats for CSN5-targeted therapeutics. (Aging, Mar 2024, https://doi.org/10.18632/aging.205646; bioRxiv, Apr 2023, https://doi.org/10.1101/2023.04.11.536468) (liu2024cop9signalosomecomplex pages 12-16, giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)

Limitations and open questions
- CSN8-specific enzymology: Unlike CSN5, CSN8 does not harbor catalytic deneddylase activity; its precise structural contributions to substrate selection and complex dynamics in human cells remain active areas of research.
- Context dependence: CSN5 inhibition phenotypes differ when CSN8 is hypomorphic, suggesting that COPS8 status may stratify responses to CSN-directed interventions and favor local over systemic delivery in vascular indications. (bioRxiv, Apr 2023, https://doi.org/10.1101/2023.04.11.536468) (giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20)

References (URLs and dates included above; citations by context IDs): (dubiel2024comparisonoftwo pages 4-5, liu2024cop9signalosomecomplex pages 12-16, giri2023cop9signalosomepromotes pages 1-5, giri2023cop9signalosomepromotes pages 17-20, sun2021cops8incutaneous pages 6-8, liu2024cop9signalosomecomplex pages 20-21)

References

1. (dubiel2024comparisonoftwo pages 4-5): Dawadschargal Dubiel and Wolfgang Dubiel. Comparison of two ups regulators: the 26s proteasome lid and the cop9 signalosome. Frontiers in Cell and Developmental Biology, Nov 2024. URL: https://doi.org/10.3389/fcell.2024.1496862, doi:10.3389/fcell.2024.1496862. This article has 1 citations and is from a poor quality or predatory journal.

2. (liu2024cop9signalosomecomplex pages 12-16): Jiahui Liu, Dexing Han, Junfeng Xuan, Jinye Xie, Weijia Wang, Quan Zhou, and Kang Chen. Cop9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma. Aging (Albany NY), 16:5264-5287, Mar 2024. URL: https://doi.org/10.18632/aging.205646, doi:10.18632/aging.205646. This article has 3 citations.

3. (giri2023cop9signalosomepromotes pages 1-5): Samiksha Giri, Chao Suo, Ruggero Pardi, Gregory A. Fishbein, Khosrow Rezvani, Yabing Chen, and Xuejun Wang. Cop9 signalosome promotes neointimal hyperplasia via deneddylation and csn5-mediated nuclear export. BioRxiv, Apr 2023. URL: https://doi.org/10.1101/2023.04.11.536468, doi:10.1101/2023.04.11.536468. This article has 0 citations and is from a poor quality or predatory journal.

4. (giri2023cop9signalosomepromotes pages 17-20): Samiksha Giri, Chao Suo, Ruggero Pardi, Gregory A. Fishbein, Khosrow Rezvani, Yabing Chen, and Xuejun Wang. Cop9 signalosome promotes neointimal hyperplasia via deneddylation and csn5-mediated nuclear export. BioRxiv, Apr 2023. URL: https://doi.org/10.1101/2023.04.11.536468, doi:10.1101/2023.04.11.536468. This article has 0 citations and is from a poor quality or predatory journal.

5. (sun2021cops8incutaneous pages 6-8): Liangliang Sun. Cops8 in cutaneous melanoma: an oncogene that accelerates the malignant development of tumor cells and predicts poor prognosis. Bioscience, biotechnology, and biochemistry, 85 2:242-250, Feb 2021. URL: https://doi.org/10.1093/bbb/zbaa017, doi:10.1093/bbb/zbaa017. This article has 4 citations.

6. (liu2024cop9signalosomecomplex pages 20-21): Jiahui Liu, Dexing Han, Junfeng Xuan, Jinye Xie, Weijia Wang, Quan Zhou, and Kang Chen. Cop9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma. Aging (Albany NY), 16:5264-5287, Mar 2024. URL: https://doi.org/10.18632/aging.205646, doi:10.18632/aging.205646. This article has 3 citations.

## Citations

1. dubiel2024comparisonoftwo pages 4-5
2. https://doi.org/10.3389/fcell.2024.1496862;
3. https://doi.org/10.18632/aging.205646
4. https://doi.org/10.1101/2023.04.11.536468
5. https://doi.org/10.3389/fcell.2024.1496862
6. https://doi.org/10.1093/bbb/zbaa017
7. https://doi.org/10.18632/aging.205646;
8. https://doi.org/10.3389/fcell.2024.1496862,
9. https://doi.org/10.18632/aging.205646,
10. https://doi.org/10.1101/2023.04.11.536468,
11. https://doi.org/10.1093/bbb/zbaa017,